Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report
Abstract Background Immune checkpoint inhibitor (ICI) therapy is used in the management of advanced malignancies. Thyroid function abnormalities have been reported, but more evidence is needed to substantiate the subtypes and course of thyroid disease associated with this treatment. Case presentatio...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2025-07-01
|
| Colección: | Thyroid Research |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13044-025-00254-7 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|